Clinical Trial Detail

Clinical Trials

Clinical Trial Detail

Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery

Complete title: Functional Liver Imaging with Sulfur Colloid SPECT/CT in Primary and Metastatic Liver Cancer Patients Receiving Liver-Directed Treatment: A Pilot Study

Research Study Number 9646
Principal Investigator Smith Apisarnthanarax
Phase Pilot

Research Study Description

This pilot trial studies how well single photon emission computed tomography (SPECT)/computed tomography (CT) with technetium Tc-99m sulfur colloid works in measuring liver function in patients with liver cancer that has or has not spread to other place in the body who are undergoing radiation therapy or surgery. Diagnostic procedures, such as sulfur colloid SPECT/CT scans, may measure normal liver tissue before, during and after treatment and help doctors plan better treatment for liver cancer patients.

Eligibility Criteria (must meet the following to participate in this study)

Ages Eligible for Study: 19 Years and older (Adult, Senior)

Sexes Eligible for Study: All

- Patients with a diagnosis of hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma, or metastatic liver cancer planned to receive definitive doses of radiation or surgical resection are eligible

- Measurable hepatic disease and/or presence of vascular tumor thrombosis

- Diagnostic CT or magnetic resonance imaging (MRI) scan within 2 months of study entry

- There are no limits on prior therapy; patients are allowed to have prior systemic therapy, radiation therapy, radiofrequency ablation, catheter-based therapies, and surgery; patients are allowed to have concurrent chemotherapy with radiation treatment

- Ability to understand and the willingness to sign a written informed consent document

Other eligibility criteria may apply.

Exclusions (conditions that would prevent participation in this study)

- Patients unable to tolerate a SPECT/CT 99mTc-SC scan

- Patients who are not planning to adhere to the required follow up schedule as outlined in this protocol

- Pregnant women

- Women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception

- Patients unable to provide informed consent

Other exclusion criteria may apply.

Research Study Number 9646
Contact Smith Apisarnthanarax

Keywords: Liver Cancer; Solid Tumors; Neoplasms; Neoplasms, Glandular and Epithelial; Carcinoma; Carcinoma, Hepatocellular; Cholangiocarcinoma; Digestive System Diseases

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials